Nipro Corporation (TYO:8086)

Market Cap	206.64B
Revenue (ttm)	626.93B
Net Income (ttm)	5.07B
Shares Out	163.10M
EPS (ttm)	27.57
PE Ratio	45.96
Forward PE	18.62
Dividend	32.00 (2.53%)
Ex-Dividend Date	Mar 28, 2025

Volume	301,700
Average Volume	531,550
Open	1,272.50
Previous Close	1,267.00
Day's Range	1,268.50 - 1,290.50
52-Week Range	1,170.00 - 1,505.50
Beta	0.02
RSI	39.95
Earnings Date	May 12, 2025

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ products, functional products, dialysis products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products. This business also operates dialysis and training centers. The company’s Pharmaceutical-Related bu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1947
• Employees: 38,117
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 8086

Financial Performance

In 2023, Nipro's revenue was 586.79 billion, an increase of 7.63% compared to the previous year's 545.20 billion. Earnings were 11.11 billion, an increase of 142.87%.